Categories: AntimicrobialNews

Glidewell Introduces Simply Natural(TM) Digital Dentures With Antimicrobial Properties

Proprietary 3D-Printing Resin Used by Glidewell Has Been Shown In Vitro to Produce Dentures With Antibacterial and Antifungal Effects

NEWPORT BEACH, CA / ACCESSWIRE / November 14, 2024 / Glidewell, America’s largest and most innovative dental laboratory, announced today that its 3D-printed Simply Natural Digital Dentures now feature in vitro bactericidal and fungicidal effects as demonstrated via in vitro testing, eliminating >99.9% of the most common bacteria and fungi known to cause biofilm and contamination of a denture surface.

Glidewell Logo

For denture wearers, less bacteria and fungi on the surface of the printed denture can result in a “cleaner” denture, with fewer microorganisms colonizing. This can lead to longer denture life and a more pleasant overall experience for the patient.

“Dentures are an essential treatment option, but can also be notoriously difficult to clean,” said David Morales, General Manager of Glidewell’s Removables Department. “By offering a denture with antimicrobial properties, we hope to maximize patient convenience and better safeguard their overall health.”

Simply Natural Digital Dentures are printed from Glidewell™ 3DP Denture Base Resin, developed and produced by Prismatik Dentalcraft, Inc., the in-house research and manufacturing division at Glidewell. The proprietary resin was cleared by the U.S. Food and Drug Administration in 2023 for its in vitro bactericidal and fungicidal effects, enabling Glidewell to promote the antimicrobial features of Simply Natural Digital Dentures – a first in the industry.

“We take pride as an organization in investing in and developing unique technologies to serve the dental community,” said Glidewell CEO Stephenie Goddard. “Rather than buy run-of-the-mill printable denture resins from a third party, we set out to design and obtain clearance for our own resin materials – challenging our R&D team to provide a compelling antimicrobial feature in the process.”

The formulation of the Glidewell 3DP Denture Base Resin contains silver sodium hydrogen zirconium phosphate as the antimicrobial agent. In vitro studies demonstrated >99.9% reduction coupled with long-term effectiveness against Streptococcus mutans, Streptococcus mitis, Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Candida albicans, Candida glabrata, Candida tropicalis, Methicillin-resistant Staphylococcus aureus (MRSA), and Vancomycin-resistant Enterococcus (VRE). These microorganisms have been shown to lead to diseases such as denture stomatitis and accumulate as nettlesome biofilm on the surface of a printed denture.1 MRSA and VRE are superbugs known to cause infections in hospital and intensive care units.

The company plans to conduct clinical studies to determine whether the presence of silver sodium hydrogen zirconium phosphate results in improved outcomes.

According to the American College of Prosthodontics, approximately 36 million adults in the United States suffer from edentulism and 120 million are missing at least one tooth.2 Around 90% of that population uses a denture to replace teeth and restore function.3 This number is set to grow due to the aging of the baby boomer population.

To learn more about Simply Natural Digital Dentures or the antimicrobial Glidewell 3DP Denture Base Resin, visit glidewell.com.

Citations

  1. Gendreau, Linda, and Zvi G. Loewy. “Epidemiology and etiology of denture stomatitis.” Journal of Prosthodontics: Implant, Esthetic and Reconstructive Dentistry 20.4 (2011): 251-260. Epidemiology and Etiology of Denture Stomatitis – Gendreau – 2011 – Journal of Prosthodontics – Wiley Online Library.

  2. “Facts and Figures.” American College of Prosthodontics, Oct. 2024. https://www.gotoapro.org/facts-figures/

  3. Ibid.

Contact Information
Eldon Thompson
Sr. Director of Marketing
mail@glidewelldental.com

SOURCE: Glidewell Dental

View the original press release on newswire.com.

Staff

Recent Posts

Angle PLC Announces Parsortix Based PD-L1 Assay Showcased at AACR

CTC PD-L1 assay enables longitudinal monitoring of PD-L1 status in lung cancer patients and may…

19 mins ago

Angle PLC Announces Research on HER2 Assay Kit Showcased at AACR

RESULTS FROM WORK TO DEVELOP A PARSORTIX-BASED Her2 assay KIT SHOWCASED AT INTERNATIONAL LIQUID BIOPSY…

19 mins ago

Can Independent Physicians Survive in 2025?

Learn How at an Exclusive Webinar on Nov. 20th Hosted by Medical Economics and Specialdocs …

3 hours ago

The Light Must Unite Declares November 11th as International Prayer Day for Global Peace

A Transformative Virtual Event Celebrates Unity, Hope, and Global Peace, Featuring Renowned Guests and Visionary…

6 hours ago

Acreage Reports Third Quarter 2024 Financial Results

Launched non-medical sales in Ohio with initial sales accounting for 38% of total state level…

6 hours ago

Defence Therapeutics Announces Securities for Debenture Financing

Vancouver, British Columbia--(Newsfile Corp. - November 14, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB:…

7 hours ago